Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
2018 1
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year
Filters applied: . Clear all
Page 1
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, W├╝lfing P, Shao Z, Rota Caremoli E, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer CE Jr; KATHERINE Investigators. von Minckwitz G, et al. N Engl J Med. 2019 Feb 14;380(7):617-628. doi: 10.1056/NEJMoa1814017. Epub 2018 Dec 5. N Engl J Med. 2019. PMID: 30516102 Clinical Trial.
Deposition and distribution of the total particulate matter of cigarette smoke in mice using a large-capacity smoke exposure system.
Henry CJ, Caton JE, Stokely JR, Guerin MR, Lopez A, Avery MD, Dansie DR, Henderson GM, Gayle T, Whitmire CE, Kouri RE. Henry CJ, et al. Toxicol Appl Pharmacol. 1981 May;58(3):399-409. doi: 10.1016/0041-008x(81)90092-2. Toxicol Appl Pharmacol. 1981. PMID: 7245213 No abstract available.
Feedback